Pharming Group N.V Income Statement (2019-2025) | PHAR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 53.87M60.30M43.48M49.67M52.86M52.77M46.62M50.15M54.24M96.76M42.54M54.90M66.66M81.22M55.59M74.09M74.85M92.67M-0.97M97.29M
Cost of Revenue 5.65M6.97M4.83M4.64M6.01M5.64M4.88M4.03M2.38M8.91M4.08M9.80M8.29M25.21M8.39M16.37M6.82M35.40M17.30M7.07M
Gross Profit 48.22M53.33M38.64M45.03M46.85M47.13M41.74M46.12M51.85M87.86M38.50M49.14M58.37M74.10M47.20M66.11M68.03M80.46M90.22M
Operating items
Research & Development -9.13M65.36M-0.01M-24.20M24.17M70.44M-14.86M-14.43M-12.34M-29.30M-15.62M-36.53M-20.75M-68.91M-18.52M-40.12M-20.72M-83.15M-44.84M
Selling, General & Administrative -5.55M39.50M-0.01M-15.05M15.04M37.00M-7.73M-8.69M-12.03M-16.42M-10.10M-20.96M-10.89M-55.88M-15.10M-30.71M-15.29M-70.65M-42.99M
Operating Expenses -14.69M104.86M-0.02M-39.25M39.21M107.43M-22.59M-23.13M-24.37M-45.72M-25.72M-57.50M-31.64M-124.79M-33.62M-70.83M-36.01M-153.80M-87.83M
Operating Income 22.00M18.59M6.27M10.87M-1.82M-1.77M2.83M17.82M7.76M20.65M-13.70M-8.36M1.91M-5.39M-16.31M-19.43M4.11M-8.62M3.81M90.22M
EBIT 22.00M18.59M6.27M10.87M-1.82M-1.77M2.83M17.82M7.76M20.65M-13.70M-8.36M1.91M-5.39M-16.31M-19.43M4.11M-8.62M3.81M90.22M
Non-operating items
Interest & Investment Income 0.54M0.04M0.04M0.80M0.80M2.70M2.70M
Other Non Operating Income -0.25M0.22M0.03M0.01M-0.10M-0.03M-1.19M-0.93M5.14M0.02M-0.17M
Non Operating Income -12.89M-12.71M0.01M2.48M-2.48M8.82M1.62M3.69M-4.46M-3.77M
Net income details
EBT -30.21M6.03M0.01M20.01M-20.00M12.79M4.23M19.56M7.76M23.79M-13.70M-7.57M1.91M-4.59M-16.31M-16.73M4.11M-5.92M3.81M90.22M
Tax Provisions -0.49M15.56M-0.00M-5.67M5.66M7.09M-0.77M-3.81M-0.18M-4.59M4.50M2.40M0.16M1.46M4.20M3.02M-2.55M-2.51M-5.63M
Profit After Tax 8.71M8.89M0.01M0.39M-14.34M15.98M3.46M15.74M9.10M19.20M-12.21M-10.89M3.46M-10.55M-12.45M-13.67M-1.03M-11.00M-10.34M90.22M
Equity Income -0.37M0.58M-0.08M-0.31M-0.12M-0.08M0.44M0.11M-1.21M-0.55M-0.30M-0.47M-0.48M-0.29M-0.50M-0.83M-0.44M-1.76M0.01M
Investment Income 0.07M
Income from Continuing Operations -29.72M-9.53M0.02M25.68M-25.67M5.70M5.00M23.37M7.94M28.38M-18.20M-9.96M1.75M-6.05M-20.51M-19.75M6.66M-3.41M9.43M90.22M
Consolidated Net Income -29.72M-9.53M0.02M25.68M-25.67M5.70M5.00M23.37M7.94M28.38M-18.20M-9.96M1.75M-6.05M-20.51M-19.75M6.66M-3.41M9.43M90.22M
Income towards Parent Company -29.72M20.33M0.02M14.35M-25.67M14.35M5.00M23.37M7.94M19.20M-18.20M-10.89M1.75M-10.89M-0.02-19.00-2.98-3.41M-0.02-15.0011.02
Net Income towards Common Stockholders -29.72M20.33M0.02M14.35M-25.67M14.35M5.00M23.37M7.94M19.20M-18.20M-10.89M1.75M-10.89M-0.02-19.00-2.98-3.41M-0.02-15.0011.02
Additional items
EPS (Basic) -0.050.030.000.02-0.040.020.010.040.010.03-0.03-0.020.00-0.020.000.000.00-0.010.000.000.00
Shares Outstanding (Weighted Average) 638.06M638.06M638.06M638.82M638.82M638.82M638.82M638.82M648.75M648.75M656.35M656.35M659.18M659.18M659.18M671.07M678.35M678.35M678.35M680.31M680.31M680.31M
EBITDA 22.00M18.59M6.27M10.87M-1.82M-1.77M2.83M17.82M7.76M20.65M-13.70M-8.36M1.91M-5.39M-16.31M-19.43M4.11M-8.62M3.81M90.22M
Tax Rate 1.62%55.42%8.23%42.45%